177 related articles for article (PubMed ID: 16004560)
1. Gene expression profile analysis: an emerging approach to investigate mechanisms of genotoxicity.
Aubrecht J; Caba E
Pharmacogenomics; 2005 Jun; 6(4):419-28. PubMed ID: 16004560
[TBL] [Abstract][Full Text] [Related]
2. Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity.
Ellinger-Ziegelbauer H; Aubrecht J; Kleinjans JC; Ahr HJ
Toxicol Lett; 2009 Apr; 186(1):36-44. PubMed ID: 18822359
[TBL] [Abstract][Full Text] [Related]
3. Genomic approaches for investigating mechanisms of genotoxicity.
Caba E; Aubrecht J
Toxicol Mech Methods; 2006; 16(2-3):69-77. PubMed ID: 20020999
[TBL] [Abstract][Full Text] [Related]
4. Application of toxicogenomics to genetic toxicology risk assessment.
Thybaud V; Le Fevre AC; Boitier E
Environ Mol Mutagen; 2007 Jun; 48(5):369-79. PubMed ID: 17567850
[TBL] [Abstract][Full Text] [Related]
5. Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity.
Sakai R; Kondo C; Oka H; Miyajima H; Kubo K; Uehara T
Toxicology; 2014 Jan; 315():8-16. PubMed ID: 24211769
[TBL] [Abstract][Full Text] [Related]
6. Genetic toxicity assessment: employing the best science for human safety evaluation Part VII: Why not start with a single test: a transformational alternative to genotoxicity hazard and risk assessment.
Ku WW; Aubrecht J; Mauthe RJ; Schiestl RH; Fornace AJ
Toxicol Sci; 2007 Sep; 99(1):20-5. PubMed ID: 17548889
[TBL] [Abstract][Full Text] [Related]
7. Differentiating mechanisms of toxicity using global gene expression analysis in Saccharomyces cerevisiae.
Caba E; Dickinson DA; Warnes GR; Aubrecht J
Mutat Res; 2005 Aug; 575(1-2):34-46. PubMed ID: 15878181
[TBL] [Abstract][Full Text] [Related]
8. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
9. Characterization and interlaboratory comparison of a gene expression signature for differentiating genotoxic mechanisms.
Ellinger-Ziegelbauer H; Fostel JM; Aruga C; Bauer D; Boitier E; Deng S; Dickinson D; Le Fevre AC; Fornace AJ; Grenet O; Gu Y; Hoflack JC; Shiiyama M; Smith R; Snyder RD; Spire C; Tanaka G; Aubrecht J
Toxicol Sci; 2009 Aug; 110(2):341-52. PubMed ID: 19465456
[TBL] [Abstract][Full Text] [Related]
10. Sensitive DsRed fluorescence-based reporter cell systems for genotoxicity and oxidative stress assessment.
Hendriks G; Atallah M; Raamsman M; Morolli B; van der Putten H; Jaadar H; Tijdens I; Esveldt-van Lange R; Mullenders L; van de Water B; Vrieling H
Mutat Res; 2011 May; 709-710():49-59. PubMed ID: 21382384
[TBL] [Abstract][Full Text] [Related]
11. Toxicogenomics in predictive toxicology in drug development.
Suter L; Babiss LE; Wheeldon EB
Chem Biol; 2004 Feb; 11(2):161-71. PubMed ID: 15123278
[TBL] [Abstract][Full Text] [Related]
12. Genotoxicity testing: progress and prospects for the next decade.
Turkez H; Arslan ME; Ozdemir O
Expert Opin Drug Metab Toxicol; 2017 Oct; 13(10):1089-1098. PubMed ID: 28889778
[TBL] [Abstract][Full Text] [Related]
13. Way forward in case of a false positive in vitro genotoxicity result for a cosmetic substance?
Doktorova TY; Ates G; Vinken M; Vanhaecke T; Rogiers V
Toxicol In Vitro; 2014 Feb; 28(1):54-9. PubMed ID: 24095862
[TBL] [Abstract][Full Text] [Related]
14. Toxicogenomics of A375 human malignant melanoma cells.
Cheng SL; Huang-Liu R; Sheu JN; Chen ST; Sinchaikul S; Tsay GJ
Pharmacogenomics; 2007 Aug; 8(8):1017-36. PubMed ID: 17716235
[TBL] [Abstract][Full Text] [Related]
15. Comparison of genotoxicant-modified transcriptomic responses in conventional and epigenetically stabilized primary rat hepatocytes with in vivo rat liver data.
Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
Arch Toxicol; 2012 Nov; 86(11):1703-15. PubMed ID: 23052194
[TBL] [Abstract][Full Text] [Related]
16. Literature-based compound profiling: application to toxicogenomics.
Frijters R; Verhoeven S; Alkema W; van Schaik R; Polman J
Pharmacogenomics; 2007 Nov; 8(11):1521-34. PubMed ID: 18034617
[TBL] [Abstract][Full Text] [Related]
17. Toxicogenomics in the assessment of immunotoxicity.
Baken KA; Vandebriel RJ; Pennings JL; Kleinjans JC; van Loveren H
Methods; 2007 Jan; 41(1):132-41. PubMed ID: 17161310
[TBL] [Abstract][Full Text] [Related]
18. Toxicogenomics: overview and potential applications for the study of non-covalent DNA interacting chemicals.
Li HH; Aubrecht J; Fornace AJ
Mutat Res; 2007 Oct; 623(1-2):98-108. PubMed ID: 17548094
[TBL] [Abstract][Full Text] [Related]
19. Development of a toxicogenomics signature for genotoxicity using a dose-optimization and informatics strategy in human cells.
Li HH; Hyduke DR; Chen R; Heard P; Yauk CL; Aubrecht J; Fornace AJ
Environ Mol Mutagen; 2015 Jul; 56(6):505-19. PubMed ID: 25733355
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic toxicity assessment of nanomaterials by whole-cell-array stress genes expression analysis.
Gou N; Onnis-Hayden A; Gu AZ
Environ Sci Technol; 2010 Aug; 44(15):5964-70. PubMed ID: 20586443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
